The Dividend Kings: Must-Own Stocks for Canadian Investors [Yahoo! Finance Canada]
Abbott Laboratories (ABT)
Last abbott laboratories earnings: 4/16 07:30 am
Check Earnings Report
US:NYSE Investor Relations:
abbott.com/investors.html
Company Research
Source: Yahoo! Finance Canada
Dividend Aristocrats — stocks from the S&P 500 that have increased dividends for 25 years or more. However, there's an even more distinguished group known as the Dividend Kings. In this guide, we'll explore what sets these stocks apart and discuss their appeal to Canadian investors seeking reliable, long-term returns. I'll also share some insights into a few Dividend Kings that I think are great for buy-and-hold investors. What is a Dividend King? A Dividend King is a standout member of the broader S&P 1500 Composite Index, distinguished by its ability to increase dividends for at least 50 consecutive years. This elite group of 38 stocks not only provides investors with steady income through dividends but also offers a chance to participate in market gains while experiencing less volatility and smaller drawdowns than the broader market. These companies have demonstrated exceptional resilience, successfully navigating multiple economic crises — including the 1987 stock market
Show less
Read more
Impact Snapshot
Event Time:
ABT
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ABT alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ABT alerts
High impacting Abbott Laboratories news events
Weekly update
A roundup of the hottest topics
ABT
News
- Point-of-Care Diagnostics Market Surges to USD 68.8 Billion by 2030, Propelled by 6.6% CAGR - Verified Market Reports® [Yahoo! Finance]Yahoo! Finance
- Abbott Laboratories (ABT) is Attracting Investor Attention: Here is What You Should Know [Yahoo! Finance]Yahoo! Finance
- It's 2024: Why are there still formula shortages in Canada? [Globe and Mail, The (Toronto, Canada)]Globe and Mail, The
- Abbott Laboratories (NYSE: ABT) had its "hold" rating re-affirmed by analysts at Jefferies Financial Group Inc.. They now have a $120.00 price target on the stock.MarketBeat
- Abbott and the Big Ten Conference Tackle U.S. Blood Shortages with First-of-its-Kind, Nationwide Blood Donation Competition, 'The We Give Blood Drive'PR Newswire
ABT
Earnings
- 7/18/24 - Beat
ABT
Sec Filings
- 9/13/24 - Form 4
- 9/12/24 - Form 144
- 9/4/24 - Form 4
- ABT's page on the SEC website